{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T20:37:01Z","timestamp":1792701421202,"version":"4.5.0"},"reference-count":170,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2016,4,14]],"date-time":"2016-04-14T00:00:00Z","timestamp":1460592000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2016,4,14]],"date-time":"2016-04-14T00:00:00Z","timestamp":1460592000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Gastroenterol Hepatol"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1038\/nrgastro.2016.37","type":"journal-article","created":{"date-parts":[[2016,4,14]],"date-time":"2016-04-14T08:16:27Z","timestamp":1460621787000},"page":"362-374","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":82,"title":["Experimental models of hepatitis B and C \u2014 new insights and progress"],"prefix":"10.1038","volume":"13","author":[{"given":"Emmanuel","family":"Thomas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T. Jake","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,4,14]]},"reference":[{"key":"BFnrgastro201637_CR1","doi-asserted-by":"crossref","first-page":"a021345","DOI":"10.1101\/cshperspect.a021345","volume":"5","author":"E Thomas","year":"2015","unstructured":"Thomas, E., Yoneda, M. & Schiff, E. R. Viral hepatitis: past and future of HBV and HDV. Cold Spring Harb. Perspect. Med. 5, a021345 (2015).","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"BFnrgastro201637_CR2","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1038\/nm.3183","volume":"19","author":"TJ Liang","year":"2013","unstructured":"Liang, T. J. Current progress in development of hepatitis C virus vaccines. Nat. Med. 19, 869\u2013878 (2013).","journal-title":"Nat. Med."},{"key":"BFnrgastro201637_CR3","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1056\/NEJMoa1406011","volume":"372","author":"J Zhang","year":"2015","unstructured":"Zhang, J.  et al. Long-term efficacy of a hepatitis E vaccine. N. Engl. J. Med. 372, 914\u2013922 (2015).","journal-title":"N. Engl. J. Med."},{"key":"BFnrgastro201637_CR4","doi-asserted-by":"crossref","first-page":"9598","DOI":"10.3748\/wjg.v21.i32.9598","volume":"21","author":"JL Wang","year":"2015","unstructured":"Wang, J. L.  et al. Histological outcome for chronic hepatitis B patients treated with entecavir versus lamivudine-based therapy. World J. Gastroenterol. 21, 9598\u20139606 (2015).","journal-title":"World J. Gastroenterol."},{"key":"BFnrgastro201637_CR5","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1007\/s10620-014-3336-7","volume":"60","author":"NC Tsai","year":"2015","unstructured":"Tsai, N. C.  et al. Viral suppression and cirrhosis regression with tenofovir disoproxil fumarate in Asians with chronic hepatitis B. Dig. Dis. Sci. 60, 260\u2013268 (2015).","journal-title":"Dig. Dis. Sci."},{"key":"BFnrgastro201637_CR6","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1056\/NEJMe1403619","volume":"370","author":"TJ Liang","year":"2014","unstructured":"Liang, T. J. & Ghany, M. G. Therapy of hepatitis C \u2014 back to the future. N. Engl. J. Med. 370, 2043\u20132047 (2014).","journal-title":"N. Engl. J. Med."},{"key":"BFnrgastro201637_CR7","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1056\/NEJMra1213651","volume":"368","author":"TJ Liang","year":"2013","unstructured":"Liang, T. J. & Ghany, M. G. Current future therapies hepatitis C virus infection. N. Engl. J. Med. 368, 1907\u20131917 (2013).","journal-title":"N. Engl. J. Med."},{"key":"BFnrgastro201637_CR8","first-page":"24","volume":"1","author":"C Seeger","year":"2015","unstructured":"Seeger, C. & Mason, W. S. Molecular biology of hepatitis B virus infection. Virology 1, 24\u201330 (2015).","journal-title":"Virology"},{"key":"BFnrgastro201637_CR9","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.antiviral.2015.06.002","volume":"121","author":"H Yan","year":"2015","unstructured":"Yan, H.  et al. NTCP opens the door for hepatitis B virus infection. Antiviral Res. 121, 24\u201330 (2015).","journal-title":"Antiviral Res."},{"key":"BFnrgastro201637_CR10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.antiviral.2015.06.012","volume":"121","author":"L Cheng","year":"2015","unstructured":"Cheng, L.  et al. Modeling hepatitis B virus infection, immunopathology and therapy in mice. Antiviral Res. 121, 1\u20138 (2015).","journal-title":"Antiviral Res."},{"key":"BFnrgastro201637_CR11","doi-asserted-by":"crossref","first-page":"a021352","DOI":"10.1101\/cshperspect.a021352","volume":"5","author":"WS Mason","year":"2015","unstructured":"Mason, W. S. Animal models and the molecular biology of hepadnavirus infection. Cold Spring Harb. Perspect. Med. 5, a021352 (2015).","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"BFnrgastro201637_CR12","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1002\/hep.28025","volume":"62","author":"TJ Liang","year":"2015","unstructured":"Liang, T. J.  et al. Present and future therapies of hepatitis B: from discovery to cure. Hepatology 62, 1893\u20131908 (2015).","journal-title":"Hepatology"},{"key":"BFnrgastro201637_CR13","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1136\/gutjnl-2014-308943","volume":"64","author":"MB Zeisel","year":"2015","unstructured":"Zeisel, M. B.  et al. Towards an HBV cure: state-of-the-art and unresolved questions-report of the ANRS workshop on HBV cure. Gut 64, 1314\u20131326 (2015).","journal-title":"Gut"},{"key":"BFnrgastro201637_CR14","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1146\/annurev-micro-090110-102954","volume":"65","author":"CL Murray","year":"2011","unstructured":"Murray, C. L. & Rice, C. M. Turning hepatitis C into a real virus. Annu. Rev. Microbiol. 65, 307\u2013327 (2011).","journal-title":"Annu. Rev. Microbiol."},{"key":"BFnrgastro201637_CR15","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1021\/jm401401n","volume":"57","author":"V Lohmann","year":"2014","unstructured":"Lohmann, V. & Bartenschlager, R. On the history of hepatitis C virus cell culture systems. J. Med. Chem. 57, 1627\u20131642 (2014).","journal-title":"J. Med. Chem."},{"key":"BFnrgastro201637_CR16","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1053\/j.gastro.2012.02.016","volume":"142","author":"J Bukh","year":"2012","unstructured":"Bukh, J. Animal models for the study of hepatitis C. Virus infection and related liver disease. Gastroenterology 142, 1279\u20131287.e3 (2012).","journal-title":"Gastroenterology"},{"key":"BFnrgastro201637_CR17","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.antiviral.2014.01.007","volume":"104","author":"M von Schaewen","year":"2014","unstructured":"von Schaewen, M. & Ploss, A. Murine models of hepatitis C: what can we look forward to? Antiviral Res. 104, 15\u201322 (2014).","journal-title":"Antiviral Res."},{"key":"BFnrgastro201637_CR18","doi-asserted-by":"crossref","first-page":"493","DOI":"10.2217\/fvl.13.29","volume":"8","author":"S Lagaye","year":"2013","unstructured":"Lagaye, S.  et al. Major models of HCV infection. Future Virol. 8, 493\u2013506 (2013).","journal-title":"Future Virol."},{"key":"BFnrgastro201637_CR19","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.virol.2015.03.014","volume":"479","author":"MT Catanese","year":"2015","unstructured":"Catanese, M. T. & Dorner, M. Advances in experimental systems to study hepatitis C virus in vitro and in vivo. Virology 479, 221\u2013233 (2015).","journal-title":"Virology"},{"key":"BFnrgastro201637_CR20","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1186\/1743-422X-10-239","volume":"10","author":"WH Gerlich","year":"2013","unstructured":"Gerlich, W. H. Medical virology of hepatitis B: how it began and where we are now. Virol. J. 10, 239 (2013).","journal-title":"Virol. J."},{"key":"BFnrgastro201637_CR21","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.virol.2015.02.031","volume":"479","author":"C Seeger","year":"2015","unstructured":"Seeger, C. & Mason, W. S. Molecular biology of hepatitis B virus infection. Virology 479, 672\u2013686 (2015).","journal-title":"Virology"},{"key":"BFnrgastro201637_CR22","first-page":"1","volume":"61","author":"BD Smith","year":"2012","unstructured":"Smith, B. D.  et al. Recommendations for the identification of chronic hepatitis C virus infection among persons born during 1945\u20131965. MMWR Recomm. Rep. 61, 1\u201332 (2012).","journal-title":"MMWR Recomm. Rep."},{"key":"BFnrgastro201637_CR23","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1053\/j.gastro.2010.12.032","volume":"140","author":"F Kanwal","year":"2011","unstructured":"Kanwal, F.  et al. Increasing prevalence of HCC and cirrhosis in patients with chronic hepatitis C Virus Infection. Gastroenterology 140, 1182\u20131188.e1 (2011).","journal-title":"Gastroenterology"},{"key":"BFnrgastro201637_CR24","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1001\/jama.1965.03080070025007","volume":"191","author":"BS Blumberg","year":"1965","unstructured":"Blumberg, B. S., Alter, H. J. & Visnich, S. A 'new' antigen leukemia sera. JAMA 191, 541\u2013546 (1965).","journal-title":"JAMA"},{"key":"BFnrgastro201637_CR25","first-page":"461","volume":"106","author":"JL Melnick","year":"1972","unstructured":"Melnick, J. L. & Boggs, J. D. Human volunteer and tissue culture studies of viral hepatitis. Can. Med. Assoc. J. 106, 461\u2013467 (1972).","journal-title":"Can. Med. Assoc. J."},{"key":"BFnrgastro201637_CR26","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1001\/jama.1967.03120180053006","volume":"200","author":"S Krugman","year":"1967","unstructured":"Krugman, S. Giles, J. & Hammond, J. Evidence for two distinctive clinical, epidemiological, and immunological types of infection. JAMA 200, 365\u2013373 (1967).","journal-title":"JAMA"},{"key":"BFnrgastro201637_CR27","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1126\/science.182.4116.1026","volume":"182","author":"SM Feinstone","year":"1973","unstructured":"Feinstone, S. M., Kapikian, A. Z. & Purceli, R. H. Hepatitis A: detection by immune electron microscopy of a viruslike antigen associated with acute illness. Science 182, 1026\u20131028 (1973).","journal-title":"Science"},{"key":"BFnrgastro201637_CR28","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1056\/NEJM197504102921502","volume":"292","author":"SM Feinstone","year":"1975","unstructured":"Feinstone, S. M.  et al. Transfusion-associated hepatitis not due to viral hepatitis type A or B. N. Engl. J. Med. 292, 767\u2013770 (1975).","journal-title":"N. Engl. J. Med."},{"key":"BFnrgastro201637_CR29","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1126\/science.2523562","volume":"244","author":"QL Choo","year":"1989","unstructured":"Choo, Q. L.  et al. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 244, 359\u2013362 (1989).","journal-title":"Science"},{"key":"BFnrgastro201637_CR30","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1136\/gut.18.12.997","volume":"18","author":"M Rizzetto","year":"1977","unstructured":"Rizzetto, M.  et al. Immunofluorescence detection of new antigen-antibody system (delta\/anti-delta) associated to hepatitis B virus in liver and in serum of HBsAg carriers. Gut 18, 997\u20131003 (1977).","journal-title":"Gut"},{"key":"BFnrgastro201637_CR31","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/323508a0","volume":"323","author":"KS Wang","year":"1986","unstructured":"Wang, K. S.  et al. Structure, sequence and expression of the hepatitis delta (\u03b4) viral genome. Nature 323, 508\u2013514 (1986).","journal-title":"Nature"},{"key":"BFnrgastro201637_CR32","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1159\/000282077","volume":"28","author":"M Rizzetto","year":"2010","unstructured":"Rizzetto, M. Hepatitis D: clinical features and therapy. Dig. Dis. 28, 139\u2013143 (2010).","journal-title":"Dig. Dis."},{"key":"BFnrgastro201637_CR33","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/0002-9343(80)90200-4","volume":"68","author":"MS Khuroo","year":"1980","unstructured":"Khuroo, M. S. Study of an epidemic of non-A, non-B hepatitis. Possibility of another human hepatitis virus distinct from post-transfusion non-A, non-B type. Am. J. Med. 68, 818\u2013824 (1980).","journal-title":"Am. J. Med."},{"key":"BFnrgastro201637_CR34","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1126\/science.2107574","volume":"247","author":"GR Reyes","year":"1990","unstructured":"Reyes, G. R.  et al. Isolation of a cDNA from the virus responsible for enterically transmitted non-A, non-B hepatitis. Science 247, 1335\u20131339 (1990).","journal-title":"Science"},{"key":"BFnrgastro201637_CR35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2893.2008.01066.x","volume":"16","author":"I Woerz","year":"2009","unstructured":"Woerz, I., Lohmann, V. & Bartenschlager, R. Hepatitis C virus replicons: dinosaurs still business? J. Viral Hepatitis 16, 1\u20139 (2009).","journal-title":"J. Viral Hepatitis"},{"key":"BFnrgastro201637_CR36","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1038\/nrd942","volume":"1","author":"R Bartenschlager","year":"2002","unstructured":"Bartenschlager, R. Hepatitis C virus replicons: potential role for drug development. Nat. Rev. Drug Discov. 1, 911\u2013916 (2002).","journal-title":"Nat. Rev. Drug Discov."},{"key":"BFnrgastro201637_CR37","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/nature08960","volume":"465","author":"M Gao","year":"2010","unstructured":"Gao, M.  et al. Chemical genetics strategy identifies an HCV NS5A inhibitor with a potent clinical effect. Nature 465, 96\u2013U108 (2010).","journal-title":"Nature"},{"key":"BFnrgastro201637_CR38","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1128\/JVI.79.5.2689-2699.2005","volume":"79","author":"R Sumpter Jr","year":"2005","unstructured":"Sumpter, R. Jr  et al. Regulating intracellular antiviral defense and permissiveness to hepatitis C virus RNA replication through a cellular RNA helicase, RIG-I. J. Virol. 79, 2689\u20132699 (2005).","journal-title":"J. Virol."},{"key":"BFnrgastro201637_CR39","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1517\/14712590903170653","volume":"9","author":"S Naik","year":"2009","unstructured":"Naik, S. & Russell, S. J. Engineering oncolytic viruses to exploit tumor specific defects in innate immune signaling pathways. Expert Opin. Biol. Ther. 9, 1163\u20131176 (2009).","journal-title":"Expert Opin. Biol. Ther."},{"key":"BFnrgastro201637_CR40","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/newbio232057a0","volume":"232","author":"WD Brighton","year":"1971","unstructured":"Brighton, W. D., Taylor, P. E. & Zuckerma, A. J. Changes induced by hepatitis serum in cultured liver cells. Nat. New Biol. 232, 57\u201358 (1971).","journal-title":"Nat. New Biol."},{"key":"BFnrgastro201637_CR41","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1053\/bega.1999.0073","volume":"14","author":"R Bartenschlager","year":"2000","unstructured":"Bartenschlager, R. & Lohmann, V. Replication of the hepatitis C virus. Best Pract. Res. Clin. Gastroenterol. 14, 241\u2013254 (2000).","journal-title":"Best Pract. Res. Clin. Gastroenterol."},{"key":"BFnrgastro201637_CR42","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1126\/science.277.5325.570","volume":"277","author":"AA Kolykhalov","year":"1997","unstructured":"Kolykhalov, A. A.  et al. Transmission of hepatitis C by intrahepatic inoculation with transcribed RNA. Science 277, 570\u2013574 (1997).","journal-title":"Science"},{"key":"BFnrgastro201637_CR43","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1073\/pnas.84.4.1005","volume":"84","author":"MA Sells","year":"1987","unstructured":"Sells, M. A., Chen, M. L. & Acs, G. Production of hepatitis B virus particles in Hep G2 cells transfected with cloned hepatitis B virus DNA. Proc. Natl Acad. Sci. USA 84, 1005\u20131009 (1987).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrgastro201637_CR44","first-page":"3858","volume":"42","author":"H Nakabayashi","year":"1982","unstructured":"Nakabayashi, H.  et al. Growth of human hepatoma cells lines with differentiated functions in chemically defined medium. Cancer Res. 42, 3858\u20133863 (1982).","journal-title":"Cancer Res."},{"key":"BFnrgastro201637_CR45","doi-asserted-by":"crossref","first-page":"3413","DOI":"10.1002\/j.1460-2075.1992.tb05420.x","volume":"11","author":"R Bartenschlager","year":"1992","unstructured":"Bartenschlager, R. & H. Schaller, Hepadnaviral assembly is initiated by polymerase binding to the encapsidation signal in the viral RNA genome. EMBO J. 11, 3413\u20133420 (1992).","journal-title":"EMBO J."},{"key":"BFnrgastro201637_CR46","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1126\/science.285.5424.110","volume":"285","author":"V Lohmann","year":"1999","unstructured":"Lohmann, V.  et al. Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line. Science 285, 110\u2013113 (1999).","journal-title":"Science"},{"key":"BFnrgastro201637_CR47","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1126\/science.290.5498.1972","volume":"290","author":"KJ Blight","year":"2000","unstructured":"Blight, K. J., Kolykhalov, A. A. & Rice, C. M. Efficient initiation of HCV RNA replication in cell culture. Science 290, 1972\u20131974 (2000).","journal-title":"Science"},{"key":"BFnrgastro201637_CR48","doi-asserted-by":"crossref","first-page":"13001","DOI":"10.1128\/JVI.76.24.13001-13014.2002","volume":"76","author":"KJ Blight","year":"2002","unstructured":"Blight, K. J., McKeating, J. A. & Rice, C. M. Highly permissive cell lines for subgenomic and genomic hepatitis C virus RNA replication. J. Virol. 76, 13001\u201313014 (2002).","journal-title":"J. Virol."},{"key":"BFnrgastro201637_CR49","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1128\/JVI.79.1.380-392.2005","volume":"79","author":"P Friebe","year":"2005","unstructured":"Friebe, P.  et al. Kissing-loop interaction in the 3\u2032 end of the hepatitis C virus genome essential for RNA replication. J. Virol. 79, 380\u2013392 (2005).","journal-title":"J. Virol."},{"key":"BFnrgastro201637_CR50","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1053\/j.gastro.2012.09.017","volume":"144","author":"M Saeed","year":"2013","unstructured":"Saeed, M.  et al. Replication of hepatitis C virus genotype 3a in cultured cells. Gastroenterology 144, 56\u2013U137 (2013).","journal-title":"Gastroenterology"},{"key":"BFnrgastro201637_CR51","doi-asserted-by":"crossref","first-page":"5365","DOI":"10.1128\/AAC.01256-12","volume":"56","author":"M Saeed","year":"2012","unstructured":"Saeed, M.  et al. Efficient replication of genotype 3a and 4a hepatitis C virus replicons in human hepatoma cells. Antimicrob. Agents Chemother. 56, 5365\u20135373 (2012).","journal-title":"Antimicrob. Agents Chemother."},{"key":"BFnrgastro201637_CR52","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/nature14899","volume":"524","author":"M Saeed","year":"2015","unstructured":"Saeed, M.  et al. SEC14L2 enables pan-genotype HCV replication in cell culture. Nature 524, 471\u2013475 (2015).","journal-title":"Nature"},{"key":"BFnrgastro201637_CR53","doi-asserted-by":"crossref","first-page":"14416","DOI":"10.1073\/pnas.212532699","volume":"99","author":"J Bukh","year":"2002","unstructured":"Bukh, J.  et al. Mutations that permit efficient replication of hepatitis C virus RNA in Huh-7 cells prevent productive replication in chimpanzees. Proc. Natl Acad. Sci. USA 99, 14416\u201314421 (2002).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrgastro201637_CR54","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1053\/j.gastro.2003.09.023","volume":"125","author":"T Kato","year":"2003","unstructured":"Kato, T.  et al. Efficient replication of the genotype 2a hepatitis C virus subgenomic replicon. Gastroenterology 125, 1808\u20131817 (2003).","journal-title":"Gastroenterology"},{"key":"BFnrgastro201637_CR55","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1038\/nm1268","volume":"11","author":"T Wakita","year":"2005","unstructured":"Wakita, T.  et al. Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat. Med. 11, 791\u2013796 (2005).","journal-title":"Nat. Med."},{"key":"BFnrgastro201637_CR56","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1126\/science.1114016","volume":"309","author":"BD Lindenbach","year":"2005","unstructured":"Lindenbach, B. D.  et al. Complete replication of hepatitis C virus in cell culture. Science 309, 623\u2013626 (2005).","journal-title":"Science"},{"key":"BFnrgastro201637_CR57","doi-asserted-by":"crossref","first-page":"9294","DOI":"10.1073\/pnas.0503596102","volume":"102","author":"J Zhong","year":"2005","unstructured":"Zhong, J.  et al. Robust hepatitis C virus infection in vitro. Proc. Natl Acad. Sci. USA 102, 9294\u20139299 (2005).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrgastro201637_CR58","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1073\/pnas.0510727103","volume":"103","author":"M Yi","year":"2006","unstructured":"Yi, M.  et al. Production of infectious genotype 1a hepatitis C virus (Hutchinson strain) in cultured human hepatoma cells. Proc. Natl Acad. Sci. USA 103, 2310\u20132315 (2006).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrgastro201637_CR59","doi-asserted-by":"crossref","first-page":"5277","DOI":"10.1128\/JVI.02667-09","volume":"84","author":"JM Gottwein","year":"2010","unstructured":"Gottwein, J. M.  et al. Novel infectious cDNA clones of hepatitis C virus genotype 3a (strain S52) and 4a (strain ED43): genetic analyses and in vivo pathogenesis studies. J. Virol. 84, 5277\u20135293 (2010).","journal-title":"J. Virol."},{"key":"BFnrgastro201637_CR60","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1128\/JVI.02877-14","volume":"89","author":"YP Li","year":"2015","unstructured":"Li, Y. P.  et al. Efficient infectious cell culture systems of the hepatitis C virus (HCV) prototype strains HCV-1 and H77. J. Virol. 89, 811\u2013823 (2015).","journal-title":"J. Virol."},{"key":"BFnrgastro201637_CR61","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.1073\/pnas.0409666102","volume":"102","author":"T Heller","year":"2005","unstructured":"Heller, T.  et al. An in vitro model of hepatitis C virion production. Proc. Natl Acad. Sci. USA 102, 2579\u20132583 (2005).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrgastro201637_CR62","doi-asserted-by":"crossref","first-page":"4405","DOI":"10.1128\/JVI.02334-06","volume":"81","author":"T Kato","year":"2007","unstructured":"Kato, T.  et al. Production of infectious hepatitis C virus of various genotypes in cell cultures. J. Virol. 81, 4405\u20134411 (2007).","journal-title":"J. Virol."},{"key":"BFnrgastro201637_CR63","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1002\/j.1460-2075.1987.tb04807.x","volume":"6","author":"CM Chang","year":"1987","unstructured":"Chang, C. M.  et al. Production of hepatitis B virus in vitro by transient expression of cloned HBV DNA in a hepatoma cell line. EMBO J. 6, 675\u2013680 (1987).","journal-title":"EMBO J."},{"key":"BFnrgastro201637_CR64","doi-asserted-by":"crossref","first-page":"2678","DOI":"10.1073\/pnas.84.9.2678","volume":"84","author":"K Yaginuma","year":"1987","unstructured":"Yaginuma, K., Shirataka, Y., Kobayashi, M. & Koike, K. Hepatitis B virus (HBV) particles are produced in a cell culture system by transient expression of transfected HBV DNA. Proc. Natl Acad. Sci. USA 84, 2678\u20132682 (1987).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrgastro201637_CR65","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1053\/j.gastro.2006.01.001","volume":"130","author":"T Pollicino","year":"2006","unstructured":"Pollicino, T.  et al. Hepatitis B virus replication is regulated by the acetylation status of hepatitis B virus cccDNA-bound H3 and H4 histones. Gastroenterology 130, 823\u2013837 (2006).","journal-title":"Gastroenterology"},{"key":"BFnrgastro201637_CR66","doi-asserted-by":"crossref","first-page":"e00049","DOI":"10.7554\/eLife.00049","volume":"1","author":"H Yan","year":"2012","unstructured":"Yan, H.  et al. Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus. eLIFE 1, e00049 (2012).","journal-title":"eLIFE"},{"key":"BFnrgastro201637_CR67","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0092-8674(86)90364-8","volume":"47","author":"C Sureau","year":"1986","unstructured":"Sureau, C.  et al. Production of hepatitis B virus by a differentiated human hepatoma cell line after transfection with cloned circular HBV DNA. Cell 47, 37\u201347 (1986).","journal-title":"Cell"},{"key":"BFnrgastro201637_CR68","doi-asserted-by":"crossref","first-page":"10588","DOI":"10.1128\/JVI.02489-06","volume":"81","author":"S Jost","year":"2007","unstructured":"Jost, S.  et al. Induction of antiviral cytidine deaminases does not explain the inhibition of hepatitis B virus replication by interferons. J. Virol. 81, 10588\u201310596 (2007).","journal-title":"J. Virol."},{"key":"BFnrgastro201637_CR69","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1053\/j.gastro.2007.07.021","volume":"133","author":"U Protzer","year":"2007","unstructured":"Protzer, U.  et al. Antiviral activity and hepatoprotection by heme oxygenase-1 in hepatitis B virus infection. Gastroenterology 133, 1156\u20131165 (2007).","journal-title":"Gastroenterology"},{"key":"BFnrgastro201637_CR70","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1128\/AAC.41.8.1715","volume":"41","author":"SK Ladner","year":"1997","unstructured":"Ladner, S. K.  et al. Inducible expression of human hepatitis B virus (HBV) in stably transfected hepatoblastoma cells: a novel system for screening potential inhibitors of HBV replication. Antimicrob. Agents Chemother. 41, 1715\u20131720 (1997).","journal-title":"Antimicrob. Agents Chemother."},{"key":"BFnrgastro201637_CR71","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1126\/science.1243462","volume":"343","author":"J Lucifora","year":"2014","unstructured":"Lucifora, J.  et al. Specific and nonhepatotoxic degradation of nuclear hepatitis B virus cccDNA. Science 343, 1221\u20131228 (2014).","journal-title":"Science"},{"key":"BFnrgastro201637_CR72","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1002\/hep.510280432","volume":"28","author":"WE Delaney 4th","year":"1998","unstructured":"Delaney, W. E. 4th & Isom, H. C. Hepatitis B virus replication in human HepG2 cells mediated by hepatitis B virus recombinant baculovirus. Hepatology 28, 1134\u20131146 (1998).","journal-title":"Hepatology"},{"key":"BFnrgastro201637_CR73","doi-asserted-by":"crossref","first-page":"5108","DOI":"10.1128\/JVI.75.11.5108-5118.2001","volume":"75","author":"MF Sprinzl","year":"2001","unstructured":"Sprinzl, M. F.  et al. Transfer of hepatitis B virus genome by adenovirus vectors into cultured cells and mice: crossing the species barrier. J. Virol. 75, 5108\u20135118 (2001).","journal-title":"J. Virol."},{"key":"BFnrgastro201637_CR74","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1055\/s-0034-1397351","volume":"35","author":"CD Sedano","year":"2015","unstructured":"Sedano, C. D. & Sarnow, P. Interaction of host cell microRNAs with the HCV RNA genome during infection of liver cells. Semin. Liver Dis. 35, 75\u201380 (2015).","journal-title":"Semin. Liver Dis."},{"key":"BFnrgastro201637_CR75","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1126\/science.1113329","volume":"309","author":"CL Jopling","year":"2005","unstructured":"Jopling, C. L.  et al. Modulation of hepatitis C virus RNA abundance by a liver-specific MicroRNA. Science 309, 1577\u20131581 (2005).","journal-title":"Science"},{"key":"BFnrgastro201637_CR76","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1002\/hep.510290356","volume":"29","author":"CM Rice","year":"1999","unstructured":"Rice, C. M.  et al. Is CD81 the key to hepatitis C virus entry? Hepatology 29, 990\u2013992 (1999).","journal-title":"Hepatology"},{"key":"BFnrgastro201637_CR77","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1126\/science.282.5390.938","volume":"282","author":"P Pileri","year":"1998","unstructured":"Pileri, P.  et al. Binding of hepatitis C virus to CD81. Science 282, 938\u2013941 (1998).","journal-title":"Science"},{"key":"BFnrgastro201637_CR78","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1002\/hep.27227","volume":"60","author":"B Israelow","year":"2014","unstructured":"Israelow, B.  et al. HepG2 cells mount effective antiviral interferon-lambda based innate immune response hepatitis C virus infection. Hepatology 60, 1170\u20131179 (2014).","journal-title":"Hepatology"},{"key":"BFnrgastro201637_CR79","doi-asserted-by":"crossref","first-page":"12087","DOI":"10.1128\/JVI.05843-11","volume":"85","author":"CM Narbus","year":"2011","unstructured":"Narbus, C. M.  et al. HepG2 cells expressing microRNA miR-122 support entire hepatitis C virus life cycle. J. Virol. 85, 12087\u201312092 (2011).","journal-title":"J. Virol."},{"key":"BFnrgastro201637_CR80","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1053\/j.gastro.2011.12.055","volume":"142","author":"E Thomas","year":"2012","unstructured":"Thomas, E.  et al. HCV infection induces a unique hepatic innate immune response associated with robust production of type III interferons. Gastroenterology 142, 978\u2013988 (2012).","journal-title":"Gastroenterology"},{"key":"BFnrgastro201637_CR81","doi-asserted-by":"crossref","first-page":"15655","DOI":"10.1073\/pnas.232137699","volume":"99","author":"P Gripon","year":"2002","unstructured":"Gripon, P.  et al. Infection of a human hepatoma cell line by hepatitis B virus. Proc. Natl Acad. Sci. USA 99, 15655\u201315660 (2002).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrgastro201637_CR82","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1002\/hep.24386","volume":"54","author":"N Ndongo-Thiam","year":"2011","unstructured":"Ndongo-Thiam, N.  et al. Long-term propagation of serum hepatitis C virus (HCV) with production of enveloped HCV particles in human HepaRG hepatocytes. Hepatology 54, 406\u2013417 (2011).","journal-title":"Hepatology"},{"key":"BFnrgastro201637_CR83","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.cbi.2006.12.003","volume":"168","author":"A Guillouzo","year":"2007","unstructured":"Guillouzo, A.  et al. The human hepatoma HepaRG cells: a highly differentiated model for studies of liver metabolism and toxicity of xenobiotics. Chem. Biol. Interact. 168, 66\u201373 (2007).","journal-title":"Chem. Biol. Interact."},{"key":"BFnrgastro201637_CR84","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1517\/17425255.2012.685159","volume":"8","author":"TB Andersson","year":"2012","unstructured":"Andersson, T. B., Kanebratt, K. P. & Kenna, J. G. The HepaRG cell line: a unique in vitro tool for understanding drug metabolism and toxicology in human. Expert Opin. Drug Metab. Toxicol. 8, 909\u2013920 (2012).","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"BFnrgastro201637_CR85","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1002\/hep.21896","volume":"46","author":"A Schulze","year":"2007","unstructured":"Schulze, A., Gripon, P. & Urban, S. Hepatitis B virus infection initiates with a large surface protein-dependent binding to heparan sulfate proteoglycans. Hepatology 46, 1759\u20131768 (2007).","journal-title":"Hepatology"},{"key":"BFnrgastro201637_CR86","doi-asserted-by":"crossref","first-page":"3384","DOI":"10.1038\/sj.onc.1203674","volume":"19","author":"US Park","year":"2000","unstructured":"Park, U. S.  et al. Hepatitis B virus-X protein upregulates the expression of p21waf1\/cip1 and prolongs G1\u2192S transition via a p53-independent pathway in human hepatoma cells. Oncogene 19, 3384\u20133394 (2000).","journal-title":"Oncogene"},{"key":"BFnrgastro201637_CR87","doi-asserted-by":"crossref","first-page":"4801","DOI":"10.1038\/sj.onc.1205589","volume":"21","author":"KH Lan","year":"2002","unstructured":"Lan, K. H.  et al. HCV NS5A interacts with p53 and inhibits p53-mediated apoptosis. Oncogene 21, 4801\u20134811 (2002).","journal-title":"Oncogene"},{"key":"BFnrgastro201637_CR88","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.virol.2005.10.023","volume":"346","author":"K Naka","year":"2006","unstructured":"Naka, K.  et al. Hepatitis C virus NS5B delays cell cycle progression by inducing interferon-\u03b2 via Toll-like receptor 3 signaling pathway without replicating viral genomes. Virology 346, 348\u2013362 (2006).","journal-title":"Virology"},{"key":"BFnrgastro201637_CR89","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1099\/vir.0.020552-0","volume":"91","author":"SY Yu","year":"2010","unstructured":"Yu, S. Y.  et al. Hepatitis B virus polymerase inhibits RIG-I- and Toll-like receptor 3-mediated beta interferon induction in human hepatocytes through interference with interferon regulatory factor 3 activation and dampening of the interaction between TBK1\/IKK\u03b5 and DDX3. J. Virol. 91, 2080\u20132090 (2010).","journal-title":"J. Virol."},{"key":"BFnrgastro201637_CR90","doi-asserted-by":"crossref","first-page":"16739","DOI":"10.1074\/jbc.M414139200","volume":"280","author":"K Li","year":"2005","unstructured":"Li, K.  et al. Distinct poly(I-C) and virus-activated signaling pathways leading to interferon-\u03b2 production in hepatocytes. J. Biol. Chem. 280, 16739\u201316747 (2005).","journal-title":"J. Biol. Chem."},{"key":"BFnrgastro201637_CR91","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1002\/hep.24557","volume":"54","author":"L Andrus","year":"2011","unstructured":"Andrus, L.  et al. Expression of paramyxovirus V proteins promotes replication and spread of hepatitis C virus in cultures of primary human fetal liver cells. Hepatology 54, 1901\u20131912 (2011).","journal-title":"Hepatology"},{"key":"BFnrgastro201637_CR92","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/509027a","volume":"509","author":"I Hyun","year":"2014","unstructured":"Hyun, I. Policy: regulate embryos made for research. Nature 509, 27\u201328 (2014).","journal-title":"Nature"},{"key":"BFnrgastro201637_CR93","doi-asserted-by":"crossref","first-page":"629","DOI":"10.2174\/138920006778017759","volume":"7","author":"G Elaut","year":"2006","unstructured":"Elaut, G.  et al. Molecular mechanisms underlying the dedifferentiation process of isolated hepatocytes and their cultures. Curr. Drug Metab. 7, 629\u2013660 (2006).","journal-title":"Curr. Drug Metab."},{"key":"BFnrgastro201637_CR94","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1053\/j.gastro.2010.06.058","volume":"139","author":"P Podevin","year":"2010","unstructured":"Podevin, P.  et al. Production of infectious hepatitis C virus in primary cultures of human adult hepatocytes. Gastroenterology 139, 1355\u20131364 (2010).","journal-title":"Gastroenterology"},{"key":"BFnrgastro201637_CR95","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1099\/0022-1317-79-10-2367","volume":"79","author":"C Fournier","year":"1998","unstructured":"Fournier, C.  et al. In vitro infection of adult normal human hepatocytes in primary culture by hepatitis C virus. J. Virol. 79, 2367\u20132374 (1998).","journal-title":"J. Virol."},{"key":"BFnrgastro201637_CR96","first-page":"495","volume":"19","author":"JF O'Connell","year":"1999","unstructured":"O'Connell, J. F.  et al. Primary human hepatocyte culture for the study of HCV. Methods Mol. Med. 19, 495\u2013500 (1999).","journal-title":"Methods Mol. Med."},{"key":"BFnrgastro201637_CR97","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/0168-1702(88)90060-3","volume":"10","author":"PJ Rijntjes","year":"1988","unstructured":"Rijntjes, P. J., Moshage, H. J. & Yap, S. H. In vitro infection of primary cultures of cryopreserved adult human hepatocytes with hepatitis-B virus. Virus Res. 10, 95\u2013109 (1988).","journal-title":"Virus Res."},{"key":"BFnrgastro201637_CR98","doi-asserted-by":"crossref","first-page":"4136","DOI":"10.1128\/jvi.62.11.4136-4143.1988","volume":"62","author":"P Gripon","year":"1988","unstructured":"Gripon, P.  et al. Hepatitis-B virus-infection of adult human hepatocytes cultured in the presence of dimethyl-sulfoxide. J. Virol. 62, 4136\u20134143 (1988).","journal-title":"J. Virol."},{"key":"BFnrgastro201637_CR99","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1073\/pnas.86.6.1875","volume":"86","author":"T Ochiya","year":"1989","unstructured":"Ochiya, T.  et al. An in vitro system for infection with hepatitis-B virus that uses primary human-fetal hepatocytes. Proc. Natl Acad. Sci. USA 86, 1875\u20131879 (1989).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrgastro201637_CR100","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/0016-5085(94)90700-5","volume":"106","author":"PR Galle","year":"1994","unstructured":"Galle, P. R.  et al. In-vitro experimental-infection of primary human hepatocytes with hepatitis-B virus. Gastroenterology 106, 664\u2013673 (1994).","journal-title":"Gastroenterology"},{"key":"BFnrgastro201637_CR101","doi-asserted-by":"crossref","first-page":"5084","DOI":"10.1128\/JVI.75.11.5084-5089.2001","volume":"75","author":"J Kock","year":"2001","unstructured":"Kock, J.  et al. Efficient infection of primary Tupaia hepatocytes with purified human and woolly monkey hepatitis B virus. J. Virol. 75, 5084\u20135089 (2001).","journal-title":"J. Virol."},{"key":"BFnrgastro201637_CR102","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1186\/1743-422X-8-363","volume":"8","author":"S Nair","year":"2011","unstructured":"Nair, S.  et al. Differential gene expression analysis of in vitro duck hepatitis B virus infected primary duck hepatocyte cultures. Virol. J. 8, 363 (2011).","journal-title":"Virol. J."},{"key":"BFnrgastro201637_CR103","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1053\/jhep.2001.28189","volume":"34","author":"M Dandri","year":"2001","unstructured":"Dandri, M.  et al. Woodchuck hepatocytes remain permissive for hepadnavirus infection and mouse liver repopulation after cryopreservation. Hepatology 34, 824\u2013833 (2001).","journal-title":"Hepatology"},{"key":"BFnrgastro201637_CR104","doi-asserted-by":"crossref","first-page":"3141","DOI":"10.1073\/pnas.0915130107","volume":"107","author":"A Ploss","year":"2010","unstructured":"Ploss, A.  et al. Persistent hepatitis C virus infection in microscale primary human hepatocyte cultures. Proc. Natl Acad. Sci. USA 107, 3141\u20133145 (2010).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrgastro201637_CR105","doi-asserted-by":"crossref","first-page":"569","DOI":"10.2174\/138920005774832632","volume":"6","author":"A Sivaraman","year":"2005","unstructured":"Sivaraman, A.  et al. A microscale in vitro physiological model of the liver: predictive screens for drug metabolism and enzyme induction. Curr. Drug Metab. 6, 569\u2013591 (2005).","journal-title":"Curr. Drug Metab."},{"key":"BFnrgastro201637_CR106","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1002\/bit.23349","volume":"109","author":"YH Lu","year":"2012","unstructured":"Lu, Y. H.  et al. A novel 3D liver organoid system for elucidation of hepatic glucose metabolism. Biotechnol. Bioeng. 109, 595\u2013604 (2012).","journal-title":"Biotechnol. Bioeng."},{"key":"BFnrgastro201637_CR107","doi-asserted-by":"crossref","first-page":"5927","DOI":"10.1016\/j.biomaterials.2009.07.022","volume":"30","author":"L Xia","year":"2009","unstructured":"Xia, L.  et al. Laminar-flow immediate-overlay hepatocyte sandwich perfusion system for drug hepatotoxicity testing. Biomaterials 30, 5927\u20135936 (2009).","journal-title":"Biomaterials"},{"key":"BFnrgastro201637_CR108","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1038\/nbt.3377","volume":"33","author":"G Levy","year":"2015","unstructured":"Levy, G.  et al. Long-term culture and expansion of primary human hepatocytes. Nat. Biotechnol. 33, 1264\u20131271 (2015).","journal-title":"Nat. Biotechnol."},{"key":"BFnrgastro201637_CR109","volume-title":"Stem Book","author":"J Cai","year":"2008","unstructured":"Cai, J.  et al. Stem Book (Harvard Stem Cell Institute, 2008)."},{"key":"BFnrgastro201637_CR110","doi-asserted-by":"crossref","first-page":"443","DOI":"10.2174\/1389200043335414","volume":"5","author":"MJ Gomez-Lechon","year":"2004","unstructured":"Gomez-Lechon, M. J.  et al. Human hepatocytes in primary culture: the choice to investigate drug metabolism in man. Curr. Drug Metab. 5, 443\u2013462 (2004).","journal-title":"Curr. Drug Metab."},{"key":"BFnrgastro201637_CR111","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.chom.2014.01.007","volume":"15","author":"T Sheahan","year":"2014","unstructured":"Sheahan, T.  et al. Interferon lambda alleles predict innate antiviral immune responses and hepatitis C virus permissiveness. Cell Host Microbe 15, 190\u2013202 (2014).","journal-title":"Cell Host Microbe"},{"key":"BFnrgastro201637_CR112","first-page":"e1002617","volume":"8","author":"XF Wu","year":"2014","unstructured":"Wu, X. F.  et al. Productive hepatitis C virus infection of stem cell-derived hepatocytes reveals a critical transition to viral permissiveness during differentiation. PLoS Pathog. 8, e1002617 (2014).","journal-title":"PLoS Pathog."},{"key":"BFnrgastro201637_CR113","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.1073\/pnas.1121400109","volume":"109","author":"RE Schwartz","year":"2012","unstructured":"Schwartz, R. E.  et al. Modeling hepatitis C virus infection using human induced pluripotent stem cells. Proc. Natl Acad. Sci. USA 109, 2544\u20132548 (2012).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrgastro201637_CR114","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.jhep.2012.03.030","volume":"57","author":"P Roelandt","year":"2012","unstructured":"Roelandt, P.  et al. Human pluripotent stem cell-derived hepatocytes support complete replication of hepatitis C virus. J. Hepatol. 57, 246\u2013251 (2012).","journal-title":"J. Hepatol."},{"key":"BFnrgastro201637_CR115","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1053\/j.gastro.2013.07.026","volume":"145","author":"M Sourisseau","year":"2012","unstructured":"Sourisseau, M.  et al. Hepatic cells derived from induced pluripotent stem cells of pigtail macaques support hepatitis C virus infection. Gastroenterology 145, 966\u2013969.e7 (2012).","journal-title":"Gastroenterology"},{"key":"BFnrgastro201637_CR116","doi-asserted-by":"crossref","first-page":"12193","DOI":"10.1073\/pnas.1412631111","volume":"111","author":"A Shlomai","year":"2014","unstructured":"Shlomai, A.  et al. Modeling host interactions with hepatitis B virus using primary and induced pluripotent stem cell-derived hepatocellular systems. Proc. Natl Acad. Sci. USA 111, 12193\u201312198 (2014).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrgastro201637_CR117","first-page":"S1025","volume":"144","author":"RE Schwartz","year":"2013","unstructured":"Schwartz, R. E.  et al. Engineering the microenvironment of differentiating IPS derived hepatocyte-like cells enables acquisition of an adult phenotype. Gastroenterology 144, S1025\u2013S1025 (2013).","journal-title":"Gastroenterology"},{"key":"BFnrgastro201637_CR118","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1038\/nchembio.1270","volume":"9","author":"J Shan","year":"2013","unstructured":"Shan, J.  et al. Identification of small molecules for human hepatocyte expansion and iPS differentiation. Nat. Chem. Biol. 9, 514\u2013577 (2013).","journal-title":"Nat. Chem. Biol."},{"key":"BFnrgastro201637_CR119","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/nature12271","volume":"499","author":"T Takebe","year":"1985","unstructured":"Takebe, T.  et al. Vascularized and functional human liver from an iPSC-derived organ bud transplant. Nature 499, 481\u2013484 (1985).","journal-title":"Nature"},{"key":"BFnrgastro201637_CR120","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1126\/science.3865369","volume":"230","author":"FV Chisari","year":"1985","unstructured":"Chisari, F. V.  et al. A transgenic mouse model of the chronic hepatitis-B surface-antigen carrier state. Science 230, 1157\u20131160 (1985).","journal-title":"Science"},{"key":"BFnrgastro201637_CR121","doi-asserted-by":"crossref","first-page":"13825","DOI":"10.1073\/pnas.202398599","volume":"99","author":"PL Yang","year":"2002","unstructured":"Yang, P. L.  et al. Hydrodynamic injection of viral DNA: a mouse model of acute hepatitis B virus infection. Proc. Natl Acad. Sci. USA 99, 13825\u201313830 (2002).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrgastro201637_CR122","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1038\/nm.2811","volume":"18","author":"S Zeissig","year":"2013","unstructured":"Zeissig, S.  et al. Hepatitis B virus-induced lipid alterations contribute to natural killer T cell-dependent protective immunity. Nat. Med. 18, 1060\u20131068 (2013).","journal-title":"Nat. Med."},{"key":"BFnrgastro201637_CR123","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1002\/hep.510250437","volume":"25","author":"T Kawamura","year":"1997","unstructured":"Kawamura, T.  et al. Transgenic expression of hepatitis C virus structural proteins in the mouse. Hepatology 25, 1014\u20131021 (1997).","journal-title":"Hepatology"},{"key":"BFnrgastro201637_CR124","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.virol.2012.09.044","volume":"435","author":"L Sandmann","year":"2013","unstructured":"Sandmann, L. & Ploss, A. Barriers of hepatitis C virus interspecies transmission. Virology 435, 70\u201380 (2013).","journal-title":"Virology"},{"key":"BFnrgastro201637_CR125","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1038\/90968","volume":"7","author":"DF Mercer","year":"2001","unstructured":"Mercer, D. F.  et al. Hepatitis C virus replication in mice with chimeric human livers. Nat. Med. 7, 927\u2013933 (2001).","journal-title":"Nat. Med."},{"key":"BFnrgastro201637_CR126","doi-asserted-by":"crossref","first-page":"e77298","DOI":"10.1371\/journal.pone.0077298","volume":"8","author":"A Tesfaye","year":"2013","unstructured":"Tesfaye, A.  et al. Chimeric mouse model for the infection of hepatitis B and C viruses. PLoS ONE 8, e77298 (2013).","journal-title":"PLoS ONE"},{"key":"BFnrgastro201637_CR127","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1172\/JCI40094","volume":"120","author":"KD Bissig","year":"2010","unstructured":"Bissig, K. D.  et al. Human liver chimeric mice provide a model for hepatitis B and C virus infection and treatment. J. Clin. Invest. 120, 924\u2013930 (2010).","journal-title":"J. Clin. Invest."},{"key":"BFnrgastro201637_CR128","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1053\/j.gastro.2011.01.001","volume":"140","author":"ML Washburn","year":"2011","unstructured":"Washburn, M. L.  et al. A humanized mouse model to study hepatitis C virus infection, immune response, and liver disease. Gastroenterology 140, 1334\u20131344 (2011).","journal-title":"Gastroenterology"},{"key":"BFnrgastro201637_CR129","first-page":"e1004718","volume":"11","author":"MT Bility","year":"2014","unstructured":"Bility, M. T.  et al. Hepatitis B virus infection and immunopathogenesis in a humanized mouse model: induction of human-specific liver fibrosis and M2-like macrophages. PLoS Pathog. 11, e1004718 (2014).","journal-title":"PLoS Pathog."},{"key":"BFnrgastro201637_CR130","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.jhep.2013.11.010","volume":"60","author":"K Giersch","year":"2014","unstructured":"Giersch, K.  et al. Persistent hepatitis D virus mono-infection in humanized mice is efficiently converted by hepatitis B virus to a productive co-infection. J. Hepatol. 60, 538\u2013544 (2014).","journal-title":"J. Hepatol."},{"key":"BFnrgastro201637_CR131","doi-asserted-by":"crossref","first-page":"4953","DOI":"10.1172\/JCI75456","volume":"124","author":"A Carpentier","year":"2014","unstructured":"Carpentier, A.  et al. Engrafted human stem cell-derived hepatocytes establish an infectious HCV murine model. J. Clin. Invest. 124, 4953\u20134964 (2014).","journal-title":"J. Clin. Invest."},{"key":"BFnrgastro201637_CR132","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1038\/nature07684","volume":"457","author":"A Ploss","year":"2009","unstructured":"Ploss, A.  et al. Human occludin is a hepatitis C virus entry factor required for infection of mouse cells. Nature 457, 882\u2013886 (2009).","journal-title":"Nature"},{"key":"BFnrgastro201637_CR133","doi-asserted-by":"crossref","first-page":"7270","DOI":"10.1073\/pnas.0402253101","volume":"101","author":"EG Cormier","year":"2004","unstructured":"Cormier, E. G.  et al. CD81 is an entry coreceptor for hepatitis C virus. Proc. Natl Acad. Sci. USA 101, 7270\u20137274 (2004).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrgastro201637_CR134","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1038\/nature10168","volume":"474","author":"M Dorner","year":"2011","unstructured":"Dorner, M.  et al. A genetically humanized mouse model for hepatitis C virus infection. Nature 474, 208\u2013246 (2011).","journal-title":"Nature"},{"key":"BFnrgastro201637_CR135","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/nature12427","volume":"501","author":"M Dorner","year":"2013","unstructured":"Dorner, M.  et al. Completion of the entire hepatitis C virus life cycle in genetically humanized mice. Nature 501, 237\u2013241 (2013).","journal-title":"Nature"},{"key":"BFnrgastro201637_CR136","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1038\/cr.2014.116","volume":"24","author":"JZ Chen","year":"2014","unstructured":"Chen, J. Z.  et al. Persistent hepatitis C virus infections and hepatopathological manifestations in immune-competent humanized mice. Cell Res. 24, 1050\u20131066 (2014).","journal-title":"Cell Res."},{"key":"BFnrgastro201637_CR137","doi-asserted-by":"crossref","first-page":"e1004840","DOI":"10.1371\/journal.ppat.1004840","volume":"11","author":"WH He","year":"2015","unstructured":"He, W. H.  et al. Hepatitis D virus infection of mice expressing human sodium taurocholate co-transporting polypeptide. PLoS Pathog. 11, e1004840 (2015).","journal-title":"PLoS Pathog."},{"key":"BFnrgastro201637_CR138","first-page":"311","volume":"75","author":"F Deinhardt","year":"1962","unstructured":"Deinhardt, F.  et al. Studies of liver function tests in chimpanzees after inoculation with human infectious hepatitis virus. Am. J. Hyg. 75, 311\u2013321 (1962).","journal-title":"Am. J. Hyg."},{"key":"BFnrgastro201637_CR139","first-page":"316","volume":"73","author":"WD Hillis","year":"1962","unstructured":"Hillis, W. D. An outbreak of infectious hepatitis among chimpanzee handlers at a United States air force base. Am. J. Hyg. 73, 316\u2013328 (1962).","journal-title":"Am. J. Hyg."},{"key":"BFnrgastro201637_CR140","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S0140-6736(78)90132-0","volume":"1","author":"E Tabor","year":"1978","unstructured":"Tabor, E.  et al. Transmission of non-A, non-B hepatitis from man to chimpanzee. Lancet 1, 463\u2013466 (1978).","journal-title":"Lancet"},{"key":"BFnrgastro201637_CR141","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S0140-6736(78)90131-9","volume":"1","author":"HJ Alter","year":"1978","unstructured":"Alter, H. J.  et al. Transmissible agent in non-A, non-B hepatitis. Lancet 1, 459\u2013463 (1978).","journal-title":"Lancet"},{"key":"BFnrgastro201637_CR142","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1002\/hast.105","volume":"42","author":"J Kahn","year":"2012","unstructured":"Kahn, J. Raising the bar: the implications of the IOM report on the use of chimpanzees in research. Hastings Cent. Rep. 42, S27\u2013S30 (2012).","journal-title":"Hastings Cent. Rep."},{"key":"BFnrgastro201637_CR143","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1126\/science.1217521","volume":"335","author":"BM Altevogt","year":"2012","unstructured":"Altevogt, B. M.  et al. Guiding limited use of chimpanzees in research. Science 335, 41\u201342 (2012).","journal-title":"Science"},{"key":"BFnrgastro201637_CR144","doi-asserted-by":"crossref","first-page":"a021469","DOI":"10.1101\/cshperspect.a021469","volume":"5","author":"SF Wieland","year":"2015","unstructured":"Wieland, S. F. The chimpanzee model for hepatitis B virus infection. Cold Spring Harb. Perspect. Med. 5, a021469 (2015).","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"BFnrgastro201637_CR145","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1002\/hep.20268","volume":"39","author":"J Bukh","year":"2004","unstructured":"Bukh, J. A critical role for the chimpanzee model in the study of hepatitis C. Hepatology 39, 1469\u20131475 (2004).","journal-title":"Hepatology"},{"key":"BFnrgastro201637_CR146","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1038\/nature08463","volume":"461","author":"DL Thomas","year":"2009","unstructured":"Thomas, D. L.  et al. Genetic variation in IL28B and spontaneous clearance of hepatitis C virus. Nature 461, 798\u2013801 (2009).","journal-title":"Nature"},{"key":"BFnrgastro201637_CR147","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/ng.2521","volume":"45","author":"L Prokunina-Olsson","year":"2013","unstructured":"Prokunina-Olsson, L.  et al. A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus. Nat. Genet. 45, 164\u2013171 (2013).","journal-title":"Nat. Genet."},{"key":"BFnrgastro201637_CR148","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1073\/pnas.91.4.1294","volume":"91","author":"QL Choo","year":"1994","unstructured":"Choo, Q. L.  et al. Vaccination of chimpanzees against infection by the hepatitis C virus. Proc. Natl Acad. Sci. USA 91, 1294\u20131298 (1994).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrgastro201637_CR149","doi-asserted-by":"crossref","first-page":"13779","DOI":"10.1128\/JVI.78.24.13779-13792.2004","volume":"78","author":"CB Bigger","year":"2004","unstructured":"Bigger, C. B.  et al. Intrahepatic gene expression during chronic hepatitis C virus infection in chimpanzees. J. Virol. 78, 13779\u201313792 (2004).","journal-title":"J. Virol."},{"key":"BFnrgastro201637_CR150","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1126\/science.1178178","volume":"327","author":"RE Lanford","year":"2010","unstructured":"Lanford, R. E.  et al. Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection. Science 327, 198\u2013201 (2010).","journal-title":"Science"},{"key":"BFnrgastro201637_CR151","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1538\/expanim.63.367","volume":"63","author":"K Tsukiyama-Kohara","year":"2014","unstructured":"Tsukiyama-Kohara, K. & Kohara, M. Tupaia belangeri as an experimental animal model for viral infection. Exp. Anim. 63, 367\u2013374 (2014).","journal-title":"Exp. Anim."},{"key":"BFnrgastro201637_CR152","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s00281-012-0335-7","volume":"35","author":"M Dandri","year":"2013","unstructured":"Dandri, M., Lutgehetmann, M. & Petersen, J. Experimental models and therapeutic approaches for HBV. Semin. Immunopathol. 35, 7\u201321 (2013).","journal-title":"Semin. Immunopathol."},{"key":"BFnrgastro201637_CR153","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/hep.510240101","volume":"24","author":"E Walter","year":"1996","unstructured":"Walter, E.  et al. Hepatitis B virus infection of tupaia hepatocytes in vitro and in vivo. Hepatology 24, 1\u20135 (1996).","journal-title":"Hepatology"},{"key":"BFnrgastro201637_CR154","doi-asserted-by":"crossref","first-page":"4533","DOI":"10.1073\/pnas.75.9.4533","volume":"75","author":"J Summers","year":"1978","unstructured":"Summers, J., Smolec, J. M. & Snyder, R. Virus similar to human hepatitis-B virus associated with hepatitis and hepatoma in woodchucks. Proc. Natl Acad. Sci. USA 75, 4533\u20134537 (1978).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrgastro201637_CR155","doi-asserted-by":"crossref","first-page":"3997","DOI":"10.1073\/pnas.79.13.3997","volume":"79","author":"WS Mason","year":"1982","unstructured":"Mason, W. S.  et al. Asymmetric replication of duck hepatitis B virus DNA in liver cells: free minus-strand DNA. Proc. Natl Acad. Sci. USA 79, 3997\u20134001 (1982).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrgastro201637_CR156","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1006\/viro.1996.8422","volume":"229","author":"Q Di","year":"1997","unstructured":"Di, Q.  et al. Major differences between WHV and HBV in the regulation of transcription. Virology 229, 25\u201335 (1997).","journal-title":"Virology"},{"key":"BFnrgastro201637_CR157","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1002\/jmv.1890150402","volume":"15","author":"R Sprengel","year":"1985","unstructured":"Sprengel, R.  et al. Comparative sequence analysis of duck and human hepatitis B virus genomes. J. Med. Virol. 15, 323\u2013333 (1985).","journal-title":"J. Med. Virol."},{"key":"BFnrgastro201637_CR158","doi-asserted-by":"crossref","first-page":"11608","DOI":"10.1073\/pnas.1101794108","volume":"108","author":"A Kapoor","year":"2011","unstructured":"Kapoor, A.  et al. Characterization of a canine homolog of hepatitis C virus. Proc. Natl Acad. Sci. USA 108, 11608\u201311613 (2011).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrgastro201637_CR159","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1099\/vir.0.065094-0","volume":"95","author":"S Lyons","year":"2014","unstructured":"Lyons, S.  et al. Viraemic frequencies and seroprevalence of non-primate hepacivirus and equine pegiviruses in horses and other mammalian species. J. Gen. Virol. 95, 1701\u20131711 (2014).","journal-title":"J. Gen. Virol."},{"key":"BFnrgastro201637_CR160","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1099\/vir.0.027490-0","volume":"92","author":"JT Stapleton","year":"2011","unstructured":"Stapleton, J. T.  et al. The GB viruses: a review and proposed classification of GBV-A, GBV-C (HGV), and GBV-D in genus Pegivirus within the family Flaviviridae. J. Gen. Virol. 92, 233\u2013246 (2011).","journal-title":"J. Gen. Virol."},{"key":"BFnrgastro201637_CR161","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1084\/jem.125.4.673","volume":"125","author":"F Deinhard","year":"1985","unstructured":"Deinhard, F  et al. Studies on transmission of human viral hepatitis to marmoset monkeys. 1. Transmission of disease serial passages and description of liver lesions. J. Exp. Med. 125, 673\u2013688 (1985).","journal-title":"J. Exp. Med."},{"key":"BFnrgastro201637_CR162","doi-asserted-by":"crossref","first-page":"3401","DOI":"10.1073\/pnas.92.8.3401","volume":"92","author":"JN Simons","year":"1995","unstructured":"Simons, J. N.  et al. Identification of 2 flavivirus-like genomes in the Gb hepatitis agent. Proc. Natl Acad. Sci. USA 92, 3401\u20133405 (1995).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrgastro201637_CR163","first-page":"690","volume":"56","author":"C Manickam","year":"2014","unstructured":"Manickam, C. & Reeves, R. K. Modeling HCV disease in animals: virology, immunology and pathogenesis of HCV and GBV-B infections. Front. Microbiol. 56, 690 (2014).","journal-title":"Front. Microbiol."},{"key":"BFnrgastro201637_CR164","doi-asserted-by":"crossref","first-page":"5387","DOI":"10.1128\/AAC.01186-12","volume":"56","author":"F McPhee","year":"2012","unstructured":"McPhee, F.  et al. Preclinical profile and characterization of the hepatitis C virus NS3 protease inhibitor asunaprevir (BMS-650032). Antimicrob. Agents Chemother. 56, 5387\u20135396 (2012).","journal-title":"Antimicrob. Agents Chemother."},{"key":"BFnrgastro201637_CR165","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.virol.2009.05.005","volume":"390","author":"D Chavez","year":"2009","unstructured":"Chavez, D., Guerra, B. & Lanford, R. E. Antiviral activity and host gene induction by tamarin and marmoset interferon-\u03b1 and interferon-\u03b3 in the GBV-B primary hepatocyte culture model. Virology 390, 186\u2013196 (2009).","journal-title":"Virology"},{"key":"BFnrgastro201637_CR166","doi-asserted-by":"crossref","first-page":"8194","DOI":"10.1073\/pnas.1303037110","volume":"110","author":"PL Quan","year":"2013","unstructured":"Quan, P. L.  et al. Bats are a major natural reservoir for hepaciviruses and pegiviruses. Proc. Natl Acad. Sci. USA 110, 8194\u20138199 (2013).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrgastro201637_CR167","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.cld.2015.01.006","volume":"19","author":"Z Ben Ari","year":"2013","unstructured":"Ben Ari, Z., Weitzman, E. & Safran, M. Oncogenic viruses and hepatocellular carcinoma. Clin. Liver Dis. 19, 341\u2013360 (2013).","journal-title":"Clin. Liver Dis."},{"key":"BFnrgastro201637_CR168","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.virol.2014.12.001","volume":"476","author":"EM Kennedy","year":"2015","unstructured":"Kennedy, E. M.  et al. Suppression of hepatitis B virus DNA accumulation in chronically infected cells using a bacterial CRISPR\/Cas RNA-guided DNA endonuclease. Virology 476, 196\u2013205 (2015).","journal-title":"Virology"},{"key":"BFnrgastro201637_CR169","doi-asserted-by":"crossref","first-page":"10833","DOI":"10.1038\/srep10833","volume":"5","author":"V Ramanan","year":"2015","unstructured":"Ramanan, V.  et al. CRISPR\/Cas9 cleavage of viral DNA efficiently suppresses hepatitis B virus. Sci. Rep. 5, 10833 (2015).","journal-title":"Sci. Rep."},{"key":"BFnrgastro201637_CR170","doi-asserted-by":"crossref","first-page":"e216","DOI":"10.1038\/mtna.2014.68","volume":"3","author":"C Seeger","year":"2015","unstructured":"Seeger, C. & Sohn, J. A. Targeting hepatitis B virus with CRISPR\/Cas9. Mol. Ther. Nucleic Acids 3, e216 (2015).","journal-title":"Mol. Ther. Nucleic Acids"}],"container-title":["Nature Reviews Gastroenterology & Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/nrgastro.2016.37.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/nrgastro.2016.37","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/nrgastro.2016.37.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,11]],"date-time":"2024-12-11T18:13:31Z","timestamp":1733940811000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrgastro.2016.37"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4,14]]},"references-count":170,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["BFnrgastro201637"],"URL":"https:\/\/doi.org\/10.1038\/nrgastro.2016.37","relation":{},"ISSN":["1759-5045","1759-5053"],"issn-type":[{"value":"1759-5045","type":"print"},{"value":"1759-5053","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4,14]]},"assertion":[{"value":"14 April 2016","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}